Articles
Export record to excel
File type to download
Record title
440 Activity and safety of camrelizumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced non-small-cell lung cancer
Record identifier
TN_cdi_proquest_journals_2552999478
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552999478
Share
440 Activity and safety of camrelizumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced non-small-cell lung cancer
- Online access available on login with a Library card.
440 Activity and safety of camrelizumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced non-small-cell lung cancer
Full title
Author / Creator
Publisher
London: BMJ Publishing Group LTD
Journal title
Record Identifier
Language
English
Formats
Publication information
Publisher
Subjects
More information
— SCOPE AND CONTENTS
Contents
— ALTERNATIVE TITLES
Full title
— AUTHORS, ARTISTS AND CONTRIBUTORS
Author / Creator
Identifiers
— PRIMARY IDENTIFIERS
Record Identifier
TN_cdi_proquest_journals_2552999478
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2552999478